Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 2441-2450 of 2808 for

Edit search filters
  1. DNA Damage Using hERY-MNT Technology can Predict Chemotherapy Induced Toxicity in Women with Ovarian Cancer

    Rochester, MN

  2. Determining if a PET/MRI can predict complete response from chemoradiotherapy before surgery in patients with locally advanced rectal cancer

    Rochester, MN

  3. A Study of Performing Surgery for Resectable Malignant Pleural Mesothelioma After Radiation Therapy

    Rochester, MN

  4. Evaluation of a Patient-Reported Symptom Index for NMIBC

    Rochester, MN

  5. Viscoelastic Parameters Estimation and Imaging for the Assessment of Axillary Lymph Nodes

    Rochester, MN

  6. Genetic Analysis in Blood and Tumor Samples From Patients With Advanced or Metastatic Estrogen Receptor Positive and HER2 Negative Breast Cancer Receiving Palbociclib and Endocrine Therapy

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  7. Simplified Patient Care Strategy in Decreasing Early Death in Patients With Acute Promyelocytic Leukemia

    Jacksonville, FL, Rochester, MN

  8. Immunomodulation and Patients` Outcomes Following Treatment of Hepatocellular Carcinoma by Radiofrequency Ablation, Microwave Ablation, Trans-Arterial Chemoembolization or Radio-embolization

    Rochester, MN

  9. University of California Minority Patient-Derived Xenograft (PDX) Development and Trial Center (UCaMP) to Reduce Cancer Health Disparities

    Jacksonville, FL

  10. Molecular Characterization of Renal Cell Carcinomas and Melanomas

    Scottsdale/Phoenix, AZ, Rochester, MN

.

Mayo Clinic Footer